February 2024 FDA Recall Voriconazole by Lupin Pharmaceuticals Inc.
D-0337-2024 - Labeling

This Class II drug recall was voluntarily initiated by Lupin Pharmaceuticals Inc. on February 5, 2024 for the product Voriconazole. The FDA reported the reason for recall as labeling. The product was distributed in OH, IL, NJ and the recall is currently terminated.

Recall Number: D-0337-2024

Reason for Recall
Labeling: Incorrect or Missing Package Insert
Initiated
02-05-2024
Reported
02-28-2024
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Lupin Pharmaceuticals Inc.
Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the bottle to release the powder. Add 50mL of water to the bottle and shake vigorously for 1 minute. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202. NDC: 43386-038-60.

Batch or Lot Expiration Information

Lot# : S200756; Exp. 10/2024
Lot# : S300218; Exp. 04/2025
Lot# : S300633; Exp. 09/2025

Affected Packages Involved in this Recall